XML 53 R42.htm IDEA: XBRL DOCUMENT
v3.25.1

Schedule of Anti-dilutive Securities Excluded from Earnings Per Share (Details) - USD ($) | 3 Months Ended
--- | ---
Mar. 31, 2025 | Mar. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |  |
Potentially Dilutive Security Resulting Common Shares |  | 327,379,344 |  | 21,203,829
Merger Options [Member] |  |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |  |
Potentially Dilutive Security Quantity | [1] | 5,666,666 |  |
Potentially Dilutive Security Stated Value Per Share | [1] |  |  |
Potentially Dilutive Security Total Value or Stated Value | [1] |  |  |
Potentially Dilutive Security Assumed Conversion Price | [1] |  |  |
Potentially Dilutive Security Resulting Common Shares | [1] | 5,666,666 |  |
Restricted Stock Units (RSUs) [Member] |  |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |  |
Potentially Dilutive Security Quantity | [2] | 1,059,432 |  |
Potentially Dilutive Security Stated Value Per Share | [2] |  |  |
Potentially Dilutive Security Total Value or Stated Value | [2] |  |  |
Potentially Dilutive Security Assumed Conversion Price | [2] |  |  |
Potentially Dilutive Security Resulting Common Shares | [2] | 1,059,432 |  |
Warrant [Member] |  |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |  |
Potentially Dilutive Security Quantity |  | 382,914,964 | [3] | 365,323,672
Potentially Dilutive Security Stated Value Per Share |  |  | [3] |
Potentially Dilutive Security Total Value or Stated Value |  |  | [3] |
Potentially Dilutive Security Assumed Conversion Price |  |  | [3] |
Potentially Dilutive Security Resulting Common Shares |  | 163,975,543 | [3] | 12,775,829
Series D Preferred Stock [Member] |  |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |  |
Potentially Dilutive Security Quantity |  | 5,982 |  | 19,402
Potentially Dilutive Security Stated Value Per Share |  | $ 1,000 |  | $ 1,000
Potentially Dilutive Security Total Value or Stated Value |  | $ 5,981,680 |  | $ 19,402,130
Potentially Dilutive Security Assumed Conversion Price |  | $ 5.00 |  | $ 5.00
Potentially Dilutive Security Resulting Common Shares |  | 1,196,337 |  | 3,880,426
Series F Preferred Stock [Member] |  |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |  |
Potentially Dilutive Security Quantity | [4] | 147,250 |  |
Potentially Dilutive Security Stated Value Per Share | [4] | $ 1,000 |  |
Potentially Dilutive Security Total Value or Stated Value | [4] | $ 147,250,000 |  |
Potentially Dilutive Security Assumed Conversion Price | [4] | $ 1,055.90 |  |
Potentially Dilutive Security Resulting Common Shares | [4] | 155,481,366 |  |
Equity Option [Member] |  |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |  |
Potentially Dilutive Security Quantity | [5] |  |  | 8,547,574
Potentially Dilutive Security Stated Value Per Share | [5] |  |  |
Potentially Dilutive Security Total Value or Stated Value | [5] |  |  |
Potentially Dilutive Security Assumed Conversion Price | [5] |  |  |
Potentially Dilutive Security Resulting Common Shares | [5] |  |  | 547,574
Series E Preferred Stock [Member] |  |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |  |
Potentially Dilutive Security Quantity |  |  |  | 20,000
Potentially Dilutive Security Stated Value Per Share |  |  |  | $ 1,000
Potentially Dilutive Security Total Value or Stated Value |  |  |  | $ 20,000,000
Potentially Dilutive Security Assumed Conversion Price |  |  |  | $ 5.00
Potentially Dilutive Security Resulting Common Shares |  |  |  | 4,000,000
[1] | The Merger Options became exercisable upon the closing of the Bayswater Acquisition on March 26, 2025. Refer to Note 15 – Common Stock Options and Warrants for a discussion of the Merger Options (defined herein).
[2] | As of March 31, 2025, all restricted stock and performance stock units presented are unvested. Refer to Note 16 – Long–Term Incentive Compensation for a discussion of the restricted stock units and performance stock units.
[3] | Includes the maximum amount of Series F Preferred Stock Warrants as of March 31, 2025, none of which have been issued. Refer to Note 15 – Common Stock Options and Warrants for a discussion of the Series F Preferred Stock Warrants.
[4] | Assumes the maximum number of converted shares using the Alternative Conversion at the NASDAQ minimum floor price, as defined in the Series F Preferred Stock Certificate of Designation (as defined herein), as of March 31, 2025. Refer to Note 13 – Mezzanine Equity for a discussion of the Series F Preferred Stock Warrants.
[5] | Not exercisable or vested as of March 31, 2024. Refer to Note 15 – Common Stock Options and Warrants for a discussion of the Merger Options and Note 16 – Long–Term Incentive Compensation for a discussion of the restricted stock units.

X
- Definition Share Value Price Per Share. + References No definition available. + Details
Name: | PROP_ShareValuePricePerShare
Namespace Prefix: | PROP_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total value or stated value. + References No definition available. + Details
Name: | PROP_StockIssuedDuringPeriodValueConversionsOfConvertibleSecurities
Namespace Prefix: | PROP_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The price per share of the conversion feature embedded in the debt instrument. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5 + Details
Name: | us-gaap_DebtInstrumentConvertibleConversionPrice1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=PROP_MergerOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesDPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesFPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesEPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |